Jury Finds Pfizer's Protonix Patent Valid
The jury in the U.S. District Court for the District of New Jersey on Friday disagreed with allegations by the generic-drug firms that the patent was invalid based on obviousness and double-patenting.
The patent, U.S. Patent Number 4,758,579, covers certain compounds useful for inhibiting gastric acid secretion, including pantoprazole sodium,...
Already a subscriber? Click here to login